High Engraftment and Metastatic Rates in Orthotopic Xenograft Models of Gastric Cancer via Direct Implantation of Tumor Cell Suspensions

• Published in: Cancers Vol. 16; no. 4; p. 759
• Main Authors: Wang, Chao, Xie, Guo-Min, Zhang, Li-Ping, Yan, Shuo, Xu, Jia-Li, Han, Yun-Lin, Luo, Ming-Jie, Gong, Jia-Nan
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 01.02.2024
• Subjects: Abdomen; Animal models; Bioluminescence; Cancer; Cell suspensions; Cells; Comparative analysis; Females; Gastric cancer; Health aspects; Ketamine; Laboratory animals; Luciferase; Metastases; Metastasis; Stomach cancer; Sutures; Tumor cells; Tumors; Xenografts; China; Beijing China; United States > US; gastric cancer; orthotopic xenograft model; metastasis; tumor invasion
• ISSN: 2072-6694; 2072-6694
• DOI: 10.3390/cancers16040759

Although the implantation of intact tumor fragments is a common practice to generate orthotopic xenografts to study tumor invasion and metastasis, the direct implantation of tumor cell suspensions is necessary when prior manipulations of tumor cells are required. However, the establishment of orthotopic xenografts using tumor cell suspensions is not mature, and a comparative study directly comparing their engraftment and metastatic capabilities is lacking. It is unclear whether tumor fragments are superior to cell suspensions for successful engraftment and metastasis. In this study, we employed three GC cell lines with varying metastatic capacities to stably express firefly luciferase for monitoring tumor progression in real time. We successfully minimized the risk of cell leakage during the orthotopic injection of tumor cell suspensions without Corning Matrigel by systematically optimizing the surgical procedure, injection volume, and needle size options. Comparable high engraftment and metastatic rates between these two methods were demonstrated using MKN-45 cells with a strong metastatic ability. Importantly, our approach can adjust the rate of tumor progression flexibly and cuts the experimental timeline from 10-12 weeks (for tumor fragments) to 4-5 weeks. Collectively, we provided a highly reproducible procedure with a shortened experimental timeline and low cost for establishing orthotopic GC xenografts via the direct implantation of tumor cell suspensions.